Furthermore, studies have revealed that inhibition of necroptosis via RIPK3 ablation in dietary-related mouse models reduces NASH-related liver inflammation and fibrosis (97, 98). The gene discussed is RIPK3; the disease is metabolic dysfunction-associated steatohepatitis.